- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Sectors
Bringg fetches $100m at a $1bn valuation
GLP, Salesforce Ventures and Siemens' Next 47 unit all participated in a series E round that lifted the fulfilment software provider's overall funding to over $180m.
Jun 18, 2021Mnemo Therapeutics redeems $91m
Alexandria Venture Investments was among the participants in a series A round for the cellular cancer therapeutics developer.
Jun 18, 2021Amplitude raises $163m for debut fund
Limited partners including Alexandria Venture Investments and Royal Bank of Canada backed the healthcare technology-focused firm's first fund.
Jun 18, 2021Singh leaves JetBlue for JLL
As managing partner at JLL Spark, Singh will help manage the property technology investment fund.
Jun 18, 2021Petronas accelerates second cohort
The Malaysian-headquartered oil and gas supplier's FutureTech 2.0 accelerator has opened applications for its second cohort.
Jun 18, 2021Daily Deal Round Up: June 17, 2021
11Street and CJ Group contributed to a $71.8m round for on-demand logistics provider Barogo while Eli Lilly helped provide $66m for macrocycle drug developer Circle Pharma.
Jun 17, 2021Daily deal net: June 17, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Jun 17, 2021Emerging Leaders Q&A – Jeppe Høier, Maersk Growth
Q&A with Jeppe Høier, partner, Maersk Growth
Jun 17, 2021Waymo drives through to $2.5bn round
Alphabet, AutoNation and Magna International all returned to reinvest in the driverless car technology developer having backed a $3.2bn round last year.
Jun 17, 2021Marqeta marks off $1.41bn initial public offering
The payment card technology provider, which counts Visa, CommerzBank, CreditEase and Mastercard as investors, has added about $190m to close its IPO.
Jun 17, 2021Verve Therapeutics beats its way to $267m IPO
Broad Institute and UPenn-linked cardiovascular disease drug developer Verve priced an upscaled initial public offering above its range.
Jun 17, 2021Verve Therapeutics beats its way to $267m IPO
GV and Novo-backed cardiovascular disease drug developer Verve priced an upscaled initial public offering above its range.
Jun 17, 2021Featured Content
The CVC Funding Round DatabaseRealtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.The CVC Funding Round Database
Realtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.
CVC DirectoryFull details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.CVC Directory
Full details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.
Corporate venture building reportData from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomesCorporate venture building report
Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
